Federal authorities are concealing critical mental health and psychiatric drug records of a trans-identified individual who threatened to kill President Trump, raising alarming questions about a pattern of protection for the behavioral health industry at the expense of public safety.
Story Snapshot
- Phillip Wharton, charged with threatening to kill President Trump in August 2025, remains free on pretrial release while courts refuse to disclose mental health evaluation results or psychiatric drug history
- Court documents reveal Wharton admitted to illicit drug use and defended violent threats against the President, yet Secret Service charging papers omit any psychotropic medication information
- This case follows a disturbing pattern where law enforcement shields mental health and pharmaceutical treatment records in cases involving trans individuals and mass violence threats
- Advocacy group AbleChild connects this to similar cover-ups in the 2024 Butler assassination attempt and other incidents where psychiatric drug involvement was buried by authorities
Threats Ignored, Records Hidden
Phillip Wharton, also known as Sadie, posted explicit threats on X.com in August 2025, including a chilling message about killing the President and wearing his face as a mask. The US Capitol Police flagged these posts to the Secret Service, triggering an investigation that led to two federal counts of threatening a federal official. Despite court-ordered mental health evaluations as a condition of pretrial release, no results have been made public. Wharton admitted to using illicit drugs during Secret Service interviews and defended the threats by citing conspiracy theories about Trump’s alleged Epstein connections. The lack of disclosed psychiatric medication history raises serious concerns about what authorities are hiding.
Pattern of Pharmaceutical Protection
This case fits a troubling pattern documented by AbleChild, a nonprofit that helped craft Tennessee legislation requiring psychotropic drug testing in mass violence cases. The 2023 Nashville Covenant School shooter, Audrey Hale, was prescribed Buspirone, Lexapro, and Hydroxyzine, yet autopsy reports failed to include complete drug testing panels. Similarly, the 2018 Parkland shooter Nikolas Cruz received treatment from Henderson Behavioral Health, but records were sealed to protect the vendor. In Wharton’s case, authorities refuse to disclose whether hormone treatments or other psychiatric medications played a role, despite the individual’s trans identity suggesting probable pharmaceutical intervention. HIPAA protections are being weaponized to shield the behavioral health industry from accountability.
Butler Assassination Attempt Cover-Up Continues
The concealment of Wharton’s records mirrors the ongoing stonewalling regarding Thomas Crooks, who attempted to assassinate President Trump in Butler, Pennsylvania in 2024. Crooks’ father worked as a behavioral health care manager at Community Care Behavioral Health, a $149 million firm specializing in crisis intervention and medication compliance monitoring. Despite this direct connection to the mental health industry, coroners cremated Crooks’ body before conducting full psychotropic drug testing. Eric Trump publicly slammed Pennsylvania state authorities and the FBI in November 2025 for providing zero transparency about the shooter’s pharmaceutical history. The FBI has yet to release a final investigation report nearly two years after the incident, fueling justified suspicions of institutional cover-up.
Trans Violence Links Buried by Authorities
Recent mass violence cases involving trans-identified individuals share a common thread: authorities systematically conceal psychiatric drug information. Robert Dorgan and Jesse Van Rootselaar, both trans-identified shooters in 2025, had their mental health treatment records shielded from public scrutiny. Wharton’s case adds another data point to this pattern. The individual comes from an upper-middle-class background, making it highly probable that gender transition treatments including hormones and psychiatric medications were part of the medical history. Yet court documents remain silent on these critical facts. This selective transparency protects pharmaceutical companies and behavioral health providers while leaving Americans vulnerable to repeat incidents. The public deserves to know whether failed psychiatric treatments and dangerous drug cocktails are creating violent offenders.
Demand for Legislative Action
AbleChild’s successful push for Tennessee legislation demonstrates that transparency is achievable when citizens demand accountability. The law requires psychotropic drug testing in mass violence cases, breaking through HIPAA barriers that have long protected the psychiatric industry. Wyoming held hearings examining links between psychiatric drugs and violence, acknowledging the data gaps that authorities deliberately maintain. Congressional task force leadership has been criticized for promoting mental health funding bills while simultaneously withholding shooter mental health data from the Butler investigation. This hypocrisy reveals the institutional incentives to expand the behavioral health industrial complex rather than expose its failures. Americans must pressure lawmakers to mandate full disclosure of psychiatric treatment records in all cases involving threats or violence against public officials and mass casualty events.
Sources:
Was Alleged Assassin Receiving Mental Health Treatment and on Psychiatric Drugs?
Law Enforcement Hides Psych Drug Ties of Trump’s Would-Be Assassin
Covering Up the Behavioral Health Links to Mass Murders and Assassinations
We Know Nothing: Eric Trump Slams PA State and FBI Silence on Butler Assassination Attempt
